JAMA Neurol:多发性硬化的视网膜结构、鞘内免疫与临床病程的关系

2017-05-05 zhangfan MedSci原创

视网膜层可以反映多发性硬化病情的进展。GCIPL减少与鞘内B免疫细胞增加相关,是残疾恶化的独立危险因素,而INL水平与脑实质性活动有关。因此,视网膜光学相干断层扫描可能是一种对不同MS患者进行鉴别开展个体化治疗方案的手段

多发性硬化症(MS)患者的长期病情进展研究对于患者个体化治疗方案是十分重要的。近日研究人员就视网膜层体积与脑脊液中免疫细胞亚群和免疫球蛋白指数的相关性以及视网膜层体积单独或组合鞘内变量与MS患者病情进展的相关性进行研究。

研究招募了312名患者,其中病程短的72人作为第一组,病程较长的240人为第二组。对第一组的患者研究人员探讨常见的神经节细胞、内网状层(GCIPL)和内核层(INL)体积与免疫球蛋白指标和脑脊液中免疫细胞数的关系以及鞘内B细胞数与残疾恶化的关系,对于第一和二组患者研究内网状层体积与残疾恶化的关系。

研究招募的患者中67.9%为女性,平均年龄34岁。第一组中69.4%为女性,平均年龄31岁,平均病程1个月,研究发现GCIPL体积减少与鞘内B细胞增加(平均增加1.96%)以及鞘内IgG合成(平均脑脊液/血清IgG指数0.78)相关,INL体积与鞘内CD56自然杀伤细胞数量相关(r=0.28; P=0.007)。GCIPL体积低的患者(<1.99 mm3)其残疾恶化的风险提高6.4倍(95% CI, 1.7-24.2; P=0.007),该结果在第二组患者中也被证实。两组患者分析发现INL体积与前瞻性T2病变负荷和钆增强病变增加相关。

研究发现,视网膜层可以反映多发性硬化病情的进展。GCIPL减少与鞘内B免疫细胞增加相关,是残疾恶化的独立危险因素,而INL水平与脑实质性活动有关。因此,视网膜光学相干断层扫描可能是一种对不同MS患者进行鉴别开展个体化治疗方案的手段。

原文出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2077245, encodeId=d6ff20e724576, content=<a href='/topic/show?id=972022912f1' target=_blank style='color:#2F92EE;'>#临床病程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22912, encryptionId=972022912f1, topicName=临床病程)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Wed May 31 08:59:00 CST 2017, time=2017-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999925, encodeId=ef9e199992505, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Oct 10 14:59:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1889743, encodeId=edab1889e43b9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Tue Jun 13 06:59:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269869, encodeId=b78a12698694f, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun May 07 05:59:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194219, encodeId=1ece194219c9, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri May 05 15:59:05 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2077245, encodeId=d6ff20e724576, content=<a href='/topic/show?id=972022912f1' target=_blank style='color:#2F92EE;'>#临床病程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22912, encryptionId=972022912f1, topicName=临床病程)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Wed May 31 08:59:00 CST 2017, time=2017-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999925, encodeId=ef9e199992505, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Oct 10 14:59:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1889743, encodeId=edab1889e43b9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Tue Jun 13 06:59:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269869, encodeId=b78a12698694f, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun May 07 05:59:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194219, encodeId=1ece194219c9, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri May 05 15:59:05 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-10-10 yinhl1978
  3. [GetPortalCommentsPageByObjectIdResponse(id=2077245, encodeId=d6ff20e724576, content=<a href='/topic/show?id=972022912f1' target=_blank style='color:#2F92EE;'>#临床病程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22912, encryptionId=972022912f1, topicName=临床病程)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Wed May 31 08:59:00 CST 2017, time=2017-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999925, encodeId=ef9e199992505, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Oct 10 14:59:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1889743, encodeId=edab1889e43b9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Tue Jun 13 06:59:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269869, encodeId=b78a12698694f, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun May 07 05:59:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194219, encodeId=1ece194219c9, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri May 05 15:59:05 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-06-13 jml2009
  4. [GetPortalCommentsPageByObjectIdResponse(id=2077245, encodeId=d6ff20e724576, content=<a href='/topic/show?id=972022912f1' target=_blank style='color:#2F92EE;'>#临床病程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22912, encryptionId=972022912f1, topicName=临床病程)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Wed May 31 08:59:00 CST 2017, time=2017-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999925, encodeId=ef9e199992505, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Oct 10 14:59:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1889743, encodeId=edab1889e43b9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Tue Jun 13 06:59:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269869, encodeId=b78a12698694f, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun May 07 05:59:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194219, encodeId=1ece194219c9, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri May 05 15:59:05 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-05-07 zutt
  5. [GetPortalCommentsPageByObjectIdResponse(id=2077245, encodeId=d6ff20e724576, content=<a href='/topic/show?id=972022912f1' target=_blank style='color:#2F92EE;'>#临床病程#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22912, encryptionId=972022912f1, topicName=临床病程)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/BF4BC9769C2FF12AC93CAA0069C0696C/100, createdBy=7bb22500091, createdName=ms1292405679162969, createdTime=Wed May 31 08:59:00 CST 2017, time=2017-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999925, encodeId=ef9e199992505, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Tue Oct 10 14:59:00 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1889743, encodeId=edab1889e43b9, content=<a href='/topic/show?id=760c430895a' target=_blank style='color:#2F92EE;'>#多发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43089, encryptionId=760c430895a, topicName=多发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=04d6114, createdName=jml2009, createdTime=Tue Jun 13 06:59:00 CST 2017, time=2017-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1269869, encodeId=b78a12698694f, content=<a href='/topic/show?id=979690e33bd' target=_blank style='color:#2F92EE;'>#视网膜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90733, encryptionId=979690e33bd, topicName=视网膜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=742793, createdName=zutt, createdTime=Sun May 07 05:59:00 CST 2017, time=2017-05-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=194219, encodeId=1ece194219c9, content=学习一下谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzaiabIFicf63hKvVMjL6aJlx4yX4UcXmzX9DyibCRcicq0QtCRWMaQKh8MYjE1D3EKUBopgiaGWYuqbeR/0, createdBy=0c2b1999806, createdName=三生有幸9135, createdTime=Fri May 05 15:59:05 CST 2017, time=2017-05-05, status=1, ipAttribution=)]
    2017-05-05 三生有幸9135

    学习一下谢谢分享

    0

相关资讯

Neurology:自体造血干细胞移植治疗多发性硬化

自体造血干细胞移植免疫清除治疗可以有效缓解重度多发性硬化患者病情降低致残率提高患者生活质量

Neurology:中枢神经网络连接增加与多发性硬化认知障碍

重度认知障碍的多发性硬化患者,其默认模式网络和额顶网络与大脑的其余部分连接增加导致信息处理相互干扰引发认知能力降低

梳理维生素D功能研究新近进展

洒在脸上的阳光着实让人感觉到惬意,而且它还能带来有益于健康的效果,中波紫外线能够帮助我们合成维生素D。

NEJM:细胞因子BAFE过度表达导致自身免疫性疾病风险

TNFSF13B突变与多发性硬化和系统性红斑狼疮相关,在机体,细胞和分子不同水平造成影响。

Neurology:慢性炎症性神经病变存在脑膜增强

目的:为了评估2个学术研究医院,多发性硬化症(MS)与一些炎症和非炎症神经疾病患者,头颅MRI增强T2液体衰减反转恢复序列(FLAIR)成像显示脑膜增强(LME)特异性和发生率。方法:评估非MS或嗜神经病毒感染的254例患者3T增强 T2-FLAIR图像是否存在脑膜增强。根据临床诊断,患者被分为:(1)非MS的炎症性神经系统疾病;(2)非炎症性神经系统疾病;(3)人类T淋巴细胞白血病病毒(HTLV

Lancet Neurol:多发性硬化症的前驱症状

研究发现多发性硬化症存在可衡量的前驱症状,有助于建立一个早期识别和治疗潜在的多发性硬化症的窗口